Enzictra Tablet

Trypsin, another proteolytic enzyme, aids in the degradation of fibrin and other necrotic tissue components, thereby enhancing wound healing and resolving inflammation. Rutoside, a bioflavonoid, contributes to capillary stabilization and strengthens vascular walls, reducing capillary permeability and fragility, which helps in managing conditions associated with microcirculatory disturbances.

The synergistic action of these components makes Enzictra Tablet suitable for adjunctive therapy in acute and chronic inflammatory conditions, postoperative swelling, sports injuries, and vascular disorders such as chronic venous insufficiency and hemorrhoids. Administration should follow medical advice, considering contraindications such as hypersensitivity to any component and bleeding disorders.

Enzictra Tablet should be used with caution in patients on anticoagulant therapy. Overall, this combination offers a multifaceted approach to inflammation management and vascular health support.